-
Fox
| almost 2 years ago
It has been a big week in the world (my world) of cancer news. Time Magazine released a double issue titled, Health Special Report ; The Next Wave of Cancer Treatment, which is a must read...Four days of back-to-back presentations by scientists,...
-
Consumer Reports Health Blog
| almost 2 years ago
The 13-year study used blood tests and ultrasound scans to look for signs of ovarian cancer . Ovarian cancer doesn't usually cause early symptoms , so screening has the potential to save thousands of lives by identifying tumors early. Although...
-
Fox News
| almost 2 years ago
It has been a big week in the world (my world) of cancer news. Time Magazine released a double issue titled, Health Special Report ; The Next Wave of Cancer Treatment, which is a must read...Four days of back-to-back presentations by scientists,...
-
Dr. Len's Cancer Blog
| almost 2 years ago
June 08, 2011 I am on the plane home from the 2011 American Society of Clinical Oncology annual meeting trying to figure out the best way to write a "wrap up" blog about my sense of what I learned and saw in Chicago over the past 4 days. I wish I...
-
Newswise
| almost 2 years ago
A new drug to treat prostate cancer shows early promise, particularly against tumors that have spread to the bone, a multi-site study shows. The drug Cabozantinib is designed to target mainly two important pathways linked to the growth and spread of...
-
The Health Care Blog
| almost 2 years ago
The health care cost debate takes place on two stages using two languages, one scientific, the other economic...The scientific texts emanated over the weekend from the American Society of Clinical Oncology meeting in Chicago. Ongoing clinical trials...
-
Newswise
| almost 2 years ago
Benjamin Anderson, M.D., a researcher in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center and director of Seattle Cancer Care Alliance's Breast Health Clinic, is the 2011 recipient of the Partners in Progress award given...
-
The Birmingham News
| almost 2 years ago
A commonly used test for ovarian cancer doesn't increase a woman's chance of survival and may in fact create other health problems, according to a study from UAB and elsewhere. The study, which will appear in the Wednesday issue of the Journal of the...
-
Fox News
| almost 2 years ago
Women screened annually for ovarian cancer were just as likely to die from the disease as women who didn't have regular screening, concludes a large new study that found screening did not catch the cancers earlier as it is intended to do. Calling...
-
San Diego Union-Tribune
| almost 2 years ago
A larger group of patients (from 100 to 300) receives the drug to further evaluate its safety and to determine if it works as expected. Another group of patients often receives a placebo for comparison. Average cost per patient: $19,300 Phase 3: The...
-
Pak Tribune
| almost 2 years ago
Breast cancer cells are known to create the conditions for their own survival by communicating their needs to the healthy cells surrounding them. Now researchers have identified a molecule known as hedgehog that sits at the centre of the switchboard...
